Leland Gershell's Net Worth
-$51.1 Thousand
Who is Leland Gershell?
Leland Gershell does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Tonix Pharmaceuticals Holding Corp., and CAPRICOR THERAPEUTICS, INC..
SEC CIK
Leland Gershell's CIK is 0001563615
Past Insider Trading and Trends
2013 was Leland Gershell's most active year for acquiring shares with 9 total transactions. Leland Gershell's most active month to acquire stocks was the month of January. 2013 was Leland Gershell's most active year for disposing of shares, totalling 1 transactions. Leland Gershell's most active month to dispose stocks was the month of March. 2015 saw Leland Gershell paying a total of $39,080.00 for 56,400 shares, this is the most they've acquired in one year. In 2013 Leland Gershell cashed out on 37,500 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Tonix Pharmaceuticals Holding Corp. (TNXP) Snapshot price: $0.16
Chief Financial OfficerLeland Gershell owns 100,000 units of Common Stock which is worth $16,000.00 and 19,260 units of Common Stock, $0.001 par value which is worth $3,081.60. In the year 2013 Leland Gershell filed a total of 16 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.12% | 400 |
$5.83 | $2,330.00 | 19.26K |
Sep 28
| |||
Form 4
| +5.60% | 1K |
$7.50 | $7,500.00 | 18.86K |
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
| +38.88% | 5K |
$5.85 | $29,250.00 | 17.86K |
Feb 9
| |||
Form 4
| +37.83% | 3.53K |
$4.25 | $15,002.50 | 12.86K |
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +5.66% | 500 |
$3.40 | $1,700.00 | 9.33K |
Sep 6
| |||
Form 4
| +66.60% | 3.53K |
—
|
—
| 8.83K |
Aug 14
| |||
Form 4
| +3.92% | 200 |
$7.49 | $1,498.00 | 5.3K |
May 23 - May 24
| |||
Form 4/A
| +2.00% | 100 |
$7.49 | $749.00 | 5.1K |
May 21
| |||
Form 4
| +0.10% | 100 |
$7.49 | $749.00 | 100.1K |
May 21
| |||
Form 4
| +60.00% | 37.5K |
$0.40 | $15,000.00 | 100K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CAPRICOR THERAPEUTICS, INC. (CAPR) Snapshot price: $4.09
CHIEF FINANCIAL OFFICERLeland Gershell owns 2,100 units of Common Stock which is worth $8,589.00. In the year 2016 Leland Gershell filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.1K |
$2.40 | $5,040.00 | 2.1K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||